ORAGENICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ORAGENICS, INC. (OGEN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.05 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-16
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was 0.00 shares.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-12-31 was -2.90M shares, a 583.88% decline year-over-year.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-09-30 was 1.57M shares, a 3040.00% increase year-over-year.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2021-12-31 was 600.00K shares.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.05M shares, a 31.61% increase from fiscal 2024.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 799.58K shares, a 454.48% increase from fiscal 2023.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 144.20K shares, a 193.05% increase from fiscal 2022.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 49.21K shares, a 97.88% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 1.05M shares 10-K · filed 2026-03-16 | |||||||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | 799.58K shares 10-K · filed 2025-03-14 | ||||||
| 2024-09-30 | 799.58K shares 10-Q · filed 2024-11-13 | |||||||
| 2023-12-31 | 144.20K shares 10-K · filed 2024-03-29 | |||||||
| 2022-12-31 | -2.90M shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-04-17 | -1.33M shares derived: sum of 2 quarters · filed 2023-04-17 | 49.21K shares 10-K · filed 2023-04-17 | |||||
| 2022-09-30 | 1.57M shares derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2023-04-14 | 2.95M shares 10-Q/A · filed 2023-04-14 | ||||||
| 2022-06-30 | 1.38M shares 10-Q/A · filed 2023-04-14 | |||||||
| 2021-12-31 | 600.00K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-29 | 650.00K shares derived: sum of 2 quarters · filed 2022-07-29 | 650.00K shares derived: sum of 3 quarters · filed 2022-07-29 | 2.32M shares 10-K/A · filed 2022-07-29 | ||||
| 2021-09-30 | 50.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 50.00K shares derived: sum of 2 quarters · filed 2021-11-15 | 1.72M shares 10-Q · filed 2021-11-15 | 1.72M shares derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 1.67M shares 10-Q · filed 2021-08-16 | 1.67M shares derived: sum of 3 quarters · filed 2021-08-16 | 1.75M shares derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2021-03-31 | 1.67M shares 10-Q · filed 2021-05-03 | 1.67M shares derived: sum of 2 quarters · filed 2021-05-03 | 1.75M shares derived: sum of 3 quarters · filed 2021-05-03 | 1.99M shares derived: sum of 4 quarters · filed 2021-05-03 | ||||
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 80.00K shares derived: sum of 2 quarters · filed 2021-03-01 | 323.66K shares derived: sum of 3 quarters · filed 2021-03-01 | 3.32M shares 10-K · filed 2021-03-01 | ||||
| 2020-09-30 | 80.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | 323.66K shares derived: sum of 2 quarters · filed 2020-11-10 | 3.32M shares 10-Q · filed 2020-11-10 | |||||
| 2020-06-30 | 243.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | 3.24M shares 10-Q · filed 2020-08-14 | ||||||
| 2020-03-31 | 2.99M shares 10-Q · filed 2020-05-15 | |||||||
| 2019-12-31 | 676.16K shares 10-K · filed 2020-03-04 | |||||||
| 2018-12-31 | 1.55M shares 10-K · filed 2019-03-29 | |||||||
| 2018-06-30 | 128.00K shares 10-Q · filed 2018-08-13 | 128.00K shares 10-Q · filed 2018-08-13 | -822.40K shares derived: sum of 3 quarters · filed 2019-03-29 | -822.40K shares derived: sum of 4 quarters · filed 2019-03-29 | ||||
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-15 | -950.40K shares derived: sum of 2 quarters · filed 2019-03-29 | -950.40K shares derived: sum of 3 quarters · filed 2019-03-29 | -844.80K shares derived: sum of 4 quarters · filed 2019-03-29 | ||||
| 2017-12-31 | -950.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -950.40K shares derived: sum of 2 quarters · filed 2019-03-29 | -844.80K shares derived: sum of 3 quarters · filed 2019-03-29 | 105.60K shares 10-K · filed 2019-03-29 | ||||
| 2017-09-30 | 0.00 shares 10-Q · filed 2017-10-31 | 105.60K shares derived: sum of 2 quarters · filed 2018-08-13 | 1.06M shares 10-Q · filed 2017-10-31 | -521.88K shares derived: sum of 4 quarters · filed 2018-08-13 | ||||
| 2017-06-30 | 105.60K shares 10-Q · filed 2018-08-13 | 1.06M shares 10-Q · filed 2017-08-14 | 105.60K shares 10-Q · filed 2018-08-13 | 1.06M shares 10-Q · filed 2017-08-14 | -521.88K shares derived: sum of 3 quarters · filed 2018-08-13 | -521.88K shares derived: sum of 4 quarters · filed 2018-08-13 | ||
| 2017-03-31 | 0.00 shares 10-Q · filed 2018-05-15 | -627.48K shares derived: sum of 2 quarters · filed 2018-05-15 | -627.48K shares derived: sum of 3 quarters · filed 2018-05-15 | -327.48K shares derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | -627.48K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -627.48K shares derived: sum of 2 quarters · filed 2018-02-16 | -327.48K shares derived: sum of 3 quarters · filed 2018-02-16 | 72.53K shares 10-K · filed 2018-02-16 | 725.25K shares 10-K · filed 2017-02-27 | |||
| 2016-09-30 | 0.00 shares 10-Q · filed 2017-10-31 | 300.00K shares derived: sum of 2 quarters · filed 2017-10-31 | 700.00K shares 10-Q · filed 2017-10-31 | 718.50K shares derived: sum of 4 quarters · filed 2017-10-31 | ||||
| 2016-06-30 | 300.00K shares 10-Q · filed 2017-08-14 | 700.00K shares 10-Q · filed 2017-08-14 | 718.50K shares derived: sum of 3 quarters · filed 2017-08-14 | 718.50K shares derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | 400.00K shares 10-Q · filed 2017-05-15 | 418.50K shares derived: sum of 2 quarters · filed 2017-05-15 | 418.50K shares derived: sum of 3 quarters · filed 2017-05-15 | 428.50K shares derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | 18.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | 18.50K shares derived: sum of 2 quarters · filed 2017-02-27 | 28.50K shares derived: sum of 3 quarters · filed 2017-02-27 | 928.50K shares 10-K · filed 2017-02-27 | ||||
| 2015-09-30 | 0.00 shares 10-Q · filed 2016-11-14 | 10.00K shares derived: sum of 2 quarters · filed 2016-11-14 | 910.00K shares 10-Q · filed 2016-11-14 | 1.07M shares derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | 10.00K shares 10-Q · filed 2016-08-15 | 910.00K shares 10-Q · filed 2016-08-15 | 1.07M shares derived: sum of 3 quarters · filed 2016-05-16 | 1.07M shares derived: sum of 4 quarters · filed 2016-05-16 | ||||
| 2015-03-31 | 900.00K shares 10-Q · filed 2016-05-16 | 1.06M shares derived: sum of 2 quarters · filed 2016-05-16 | 1.06M shares derived: sum of 3 quarters · filed 2016-05-16 | 1.16M shares derived: sum of 4 quarters · filed 2016-05-16 | ||||
| 2014-12-31 | 157.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 157.50K shares derived: sum of 2 quarters · filed 2016-03-30 | 257.50K shares derived: sum of 3 quarters · filed 2016-03-30 | 257.50K shares 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | 0.00 shares 10-Q · filed 2015-11-06 | 100.00K shares derived: sum of 2 quarters · filed 2015-11-06 | 100.00K shares 10-Q · filed 2015-11-06 | 126.00K shares derived: sum of 4 quarters · filed 2015-11-06 | ||||
| 2014-06-30 | 100.00K shares 10-Q · filed 2015-08-07 | 100.00K shares 10-Q · filed 2015-08-07 | 126.00K shares derived: sum of 3 quarters · filed 2015-08-07 | 126.00K shares derived: sum of 4 quarters · filed 2015-08-07 | ||||
| 2014-03-31 | 0.00 shares 10-Q · filed 2015-05-08 | 26.00K shares derived: sum of 2 quarters · filed 2015-05-08 | 26.00K shares derived: sum of 3 quarters · filed 2015-05-08 | 51.00K shares derived: sum of 4 quarters · filed 2015-05-08 | ||||
| 2013-12-31 | 26.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | 26.00K shares derived: sum of 2 quarters · filed 2015-02-27 | 51.00K shares derived: sum of 3 quarters · filed 2015-02-27 | 61.00K shares 10-K · filed 2015-02-27 | ||||
| 2013-09-30 | 0.00 shares 10-Q · filed 2014-11-03 | 25.00K shares derived: sum of 2 quarters · filed 2014-11-03 | 35.00K shares 10-Q · filed 2014-11-03 | 35.00K shares derived: sum of 4 quarters · filed 2014-11-03 | ||||
| 2013-06-30 | 25.00K shares 10-Q · filed 2014-08-07 | 35.00K shares 10-Q · filed 2014-08-07 | 35.00K shares derived: sum of 3 quarters · filed 2014-08-07 | 35.00K shares derived: sum of 4 quarters · filed 2014-08-07 | ||||
| 2013-03-31 | 10.00K shares 10-Q · filed 2014-05-09 | 10.00K shares derived: sum of 2 quarters · filed 2014-05-09 | 10.00K shares derived: sum of 3 quarters · filed 2014-05-09 | 10.00K shares derived: sum of 4 quarters · filed 2014-05-09 | ||||
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | 0.00 shares derived: sum of 2 quarters · filed 2014-02-28 | 0.00 shares derived: sum of 3 quarters · filed 2014-02-28 | 100.00K shares 10-K · filed 2014-02-28 | ||||
| 2012-09-30 | 0.00 shares 10-Q · filed 2013-10-25 | 0.00 shares derived: sum of 2 quarters · filed 2013-10-25 | 100.00K shares 10-Q · filed 2013-10-25 | |||||
| 2012-07-30 | 30.00K shares 10-Q · filed 2012-08-10 | |||||||
| 2012-06-30 | 0.00 shares 10-Q · filed 2013-08-12 | 100.00K shares 10-Q · filed 2013-08-12 | ||||||
| 2011-12-31 | 496.50K shares 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |